Browse > Article
http://dx.doi.org/10.3345/kjp.2011.54.11.470

Familial hyperkalemic periodic paralysis caused by a de novo mutation in the sodium channel gene SCN4A  

Han, Ji-Yeon (Department of Pediatrics, Konyang University College of Medicine)
Kim, June-Bum (Department of Pediatrics, Konyang University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.54, no.11, 2011 , pp. 470-472 More about this Journal
Abstract
Familial hyperkalemic periodic paralysis (HYPP) is an autosomal-dominant channelopathy characterized by transient and recurrent episodes of paralysis with concomitant hyperkalemia. Mutations in the skeletal muscle voltage-gated sodium channel gene $SCN4A$ have been reported to be responsible for this disease. Here, we report the case of a 16-year-old girl with HYPP whose mutational analysis revealed a heterozygous c.2111C>T substitution in the $SCN4A$ gene leading to a Thr704Met mutation in the protein sequence. The parents were clinically unaffected and did not have a mutation in the $SCN4A$ gene. A $de$ $novo$ $SCN4A$ mutation for familial HYPP has not previously been reported. The patient did not respond to acetazolamide, but showed a marked improvement in paralytic symptoms upon treatment with hydrochlorothiazide. The findings in this case indicate that a $de$ $novo$ mutation needs to be considered when an isolated family member is found to have a HYPP phenotype.
Keywords
Hyperkalemic periodic paralysis; Mutation; SCN4A;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Lehmann-Horn F, Rudel R, Jurkat-Rott K. Non-dystrophic myotonias and periodic paralyses. In: Engel A, Franzini-Armstrong C, editors. Myology: basic and clinical. 3rd ed. New York: McGraw-Hill, 2004:1257-300.
2 Feero WG, Wang J, Barany F, Zhou J, Todorovic SM, Conwit R, et al. Hyperkalemic periodic paralysis: rapid molecular diagnosis and relationship of genotype to phenotype in 12 families. Neurology 1993; 43:668-73.   DOI   ScienceOn
3 Jurkat-Rott K, Lehmann-Horn F. Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis. Neurotherapeutics 2007;4:216-24.   DOI   ScienceOn
4 Paternostro-Sluga T, Grim-Stieger M, Posch M, Schuhfried O, Vacariu G, Mittermaier C, et al. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med 2008;40:665-71.   DOI   ScienceOn
5 Park YH, Kim JB. An atypical phenotype of hypokalemic periodic paralysis caused by a mutation in the sodium channel gene SCN4A. Korean J Pediatr 2010;53:909-12.   DOI
6 Ptacek L. The familial periodic paralyses and nondystrophic myotonias. Am J Med 1998;105:58-70.   DOI   ScienceOn
7 Miller TM, Dias da Silva MR, Miller HA, Kwiecinski H, Mendell JR, Tawil R, et al. Correlating phenotype and genotype in the periodic paralyses. Neurology 2004;63:1647-55.   DOI   ScienceOn
8 Kim JB, Kim MH, Lee SJ, Kim DJ, Lee BC. The Genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis. J Korean Med Sci 2007;22:946-51.   DOI   ScienceOn
9 Ricker K, Böhlen R, Rohkamm R. Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis. Neurology 1983;33:1615-8.   DOI
10 Hantai D, Richard P, Koenig J, Eymard B. Congenital myasthenic syndromes. Curr Opin Neurol 2004;17:539-51.   DOI   ScienceOn
11 Brancati F, Valente EM, Davies NP, Sarkozy A, Sweeney MG, LoMonaco M, et al. Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A. J Neurol Neurosurg Psychiatry 2003;74:1339-41.   DOI   ScienceOn
12 Bouhours M, Luce S, Sternberg D, Willer JC, Fontaine B, Tabti N. A1152D mutation of the Na+ channel causes paramyotonia congenita and emphasizes the role of DIII/S4-S5 linker in fast inactivation. J Physiol 2005;565(Pt 2):415-27.   DOI
13 Okuda S, Kanda F, Nishimoto K, Sasaki R, Chihara K. Hyperkalemic periodic paralysis and paramyotonia congenita--a novel sodium channel mutation. J Neurol 2001;248:1003-4.   DOI   ScienceOn
14 Lehmann-Horn F, Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiol Rev 1999;79:1317-72.   DOI
15 Lehmann-Horn F, Rüdel R. Molecular pathophysiology of voltage-gated ion channels. Rev Physiol Biochem Pharmacol 1996;128:195-268.